bioRxivBioinformaticsPreprint
Unraveling miRNA-Driven DNA Damage Response Networks in Pancreatic Adenocarcinoma: A Multi-Omics and Machine Learning Approach
- Citations
- 0
Abstract
Due to the late detection, aggressive nature, and paucity of treatment options, pancreatic adenocarcinoma (PAAD) remains one of the most lethal cancers worldwide. MicroRNAs (miRNAs) are small non-coding RNAs that function as oncogenes or tumor suppressors. These are highly stable in the blood circulation, hence increasingly recognized as promising biomarkers for early cancer detection. We hypothesize that certain "driver miRNAs" regulate the expression of DNA Damage Response (DDR) genes. To test this, we have built a machine learning model to integrate multi-omics data from The Cancer Genome Atlas (TCGA) PAAD cohort, including copy number alterations, DNA methylation, gene expression, and microRNA (miRNA) expression, along with curated transcription factor interactions. We predicted around 2,000 miRNA-DDR gene interaction pairs; several of these were significantly enriched in a previously known experimentally validated miRNA-target interactions. Our analysis revealed several oncogenic and tumor-suppressive miRNAs that closely correlated with patient outcomes. Importantly, we were able to identify DDR genes that were highly targeted by multiple miRNAs and strongly correlated with patient overall survival. These findings enhance our understanding of the molecular mechanisms in PAAD and open new avenues for using miRNAs as disease biomarkers and suggest target genes for precision oncology.
- organism: human
- assay: bulk RNA-seq
- assay: DNA methylation
- assay: whole-exome sequencing
- assay: long-read sequencing
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: machine learning (classical)
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification of Blood-based Non-invasive Biomarkers and Therapeutic Agents against Pancreatic Ductal Adenocarcinoma (PDAC): A Network-based Study
Md. Asad Ullah, Bishajit Sarkar, Fayza Akter·Informatics in Medicine UnlockedPeer-reviewed·Jan 1, 2020
- Identification and Interaction Analysis of Molecular Markers in Pancreatic Ductal Adenocarcinoma by Integrated Bioinformatics Analysis and Molecular Docking Experiments
Basavaraj Mallikarjunayya Vastrad, Chanabasayya Mallikarjunayya Vastrad, Anandkumar Tengli·medRxiv·Dec 20, 2020
- Machine Learning-Based Identification of Survival-Associated CpG Biomarkers in Pancreatic Ductal Adenocarcinoma
Yu Zhang, Yining Zhao, Bo Zhang·The Journal of Precision Medicine Health and DiseasePeer-reviewed·Jun 27, 2026
- Functional significance and therapeutic potential of miR-15a mimic in pancreatic ductal adenocarcinoma
- Network-based integration of gene expression and DNA methylation identifies prognostic biomarkers for early-stage pancreatic cancer
T Dhanushkumar, Krishnan Anbarasu, … Rohini Karunakaran·bioRxiv·Feb 11, 2026
- Development of Gemcitabine-Modified miRNA Mimics as Cancer Therapeutics for Pancreatic Ductal Adenocarcinoma
J. G. Yuen, G.-R. Hwang, … J. Ju·bioRxiv·Aug 14, 2023